APA (7th ed.) Citation

Burcher, K., Karukonda, P., Kelsey, C., Mullikin, T., Antonia, S. J., & Oduah, E. I. (2025). A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC. Cancers, 17(11), 1829. https://doi.org/10.3390/cancers17111829

Chicago Style (17th ed.) Citation

Burcher, Kimberly, Pooja Karukonda, Christopher Kelsey, Trey Mullikin, Scott J. Antonia, and Eziafa I. Oduah. "A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC." Cancers 17, no. 11 (2025): 1829. https://doi.org/10.3390/cancers17111829.

MLA (9th ed.) Citation

Burcher, Kimberly, et al. "A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC." Cancers, vol. 17, no. 11, 2025, p. 1829, https://doi.org/10.3390/cancers17111829.